Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Astrana Health Q1 EPS $0.14 Misses $0.23 Estimate, Sales $620.39M Miss $630.68M Estimate

Author: Benzinga Newsdesk | May 08, 2025 03:24pm
Astrana Health (NASDAQ:ASTH) reported quarterly earnings of $0.14 per share which missed the analyst consensus estimate of $0.23 by 39.13 percent. This is a 54.84 percent decrease over earnings of $0.31 per share from the same period last year. The company reported quarterly sales of $620.39 million which missed the analyst consensus estimate of $630.68 million by 1.63 percent. This is a 53.43 percent increase over sales of $404.36 million the same period last year.

Posted In: ASTH


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist